{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:11Z","timestamp":1792085531684,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>In 2023, childhood hypoglycaemia remains a major public health problem and significant risk factor for consequent adverse neurodevelopment. Irrespective of the underlying cause, key elements of clinical management include the detection, prediction and prevention of episodes of hypoglycaemia. These tasks are increasingly served by Continuous Glucose Monitoring (CGM) devices that measure subcutaneous glucose at near-continuous frequency. While the use of CGM in type 1 diabetes is well established, the evidence for widespread use in rare hypoglycaemia disorders is less than convincing. However, in the few years since our last review there have been multiple developments and increased user feedback, requiring a review of clinical application. Despite advances in device technology, point accuracy of CGM remains low for children with non-diabetes hypoglycaemia. Simple provision of CGM devices has not replicated the efficacy seen in those with diabetes and is yet to show benefit. Machine learning techniques for hypoglycaemia prevention have so far failed to demonstrate sufficient prediction accuracy for real world use even in those with diabetes. Furthermore, access to CGM globally is restricted by costs kept high by the commercially-driven speed of technical innovation. Nonetheless, the ability of CGM to digitally phenotype disease groups has led to a better understanding of natural history of disease, facilitated diagnoses and informed changes in clinical management. Large CGM datasets have prompted re-evaluation of hypoglycaemia incidence and facilitated improved trial design. Importantly, an individualised approach and focus on the behavioural determinants of hypoglycaemia has led to real world reduction in hypoglycaemia. In this state of the art review, we critically analyse the updated evidence for use of CGM in non-diabetic childhood hypoglycaemia disorders since 2020 and provide suggestions for qualified use.<\/jats:p>","DOI":"10.3389\/fendo.2023.1116864","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T06:33:55Z","timestamp":1674455635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023"],"prefix":"10.3389","volume":"14","author":[{"given":"Chris","family":"Worth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Hoskyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Salomon-Estebanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Nutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry G.J","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Beardsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indraneel","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.784932","article-title":"Health-related quality of life of children and adolescents with congenital hyperinsulinism \u2013 a scoping review","volume":"12","author":"Kristensen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.876903","article-title":"Global registries in congenital hyperinsulinism","volume":"13","author":"Pasquini","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0867-6","article-title":"The burden of congenital hyperinsulinism in the united kingdom: A cost of illness study","volume":"13","author":"Eljamel","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/J.PEC.2007.05.003","article-title":"A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education","volume":"68","author":"Wild","year":"2007","journal-title":"Patient Educ Couns"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/J.1651-2227.2001.TB00274.X","article-title":"Short-term effects of severe hypoglycaemia in children and adolescents with type 1 diabetes","volume":"90","author":"Nordfeldt","year":"2001","journal-title":"A cost-of-illness study Acta P\u00e6diatrica"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.886552","article-title":"Congenital hyperinsulinism international: A community focused on improving the lives of people living with congenital hyperinsulinism","volume":"13","author":"Raskin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jama.2022.0992","article-title":"Association of neonatal hypoglycemia with academic performance in mid-childhood","volume":"327","author":"Shah","year":"2022","journal-title":"Jama"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years","volume":"373","author":"McKinlay","year":"2015","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6659.1304","article-title":"Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia","author":"Lucas","year":"1988","journal-title":"British Medical Journal"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14152","article-title":"Complexities in the medical management of hypoglycaemia due to congenital hyperinsulinism","volume":"92","author":"Worth","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pedi.13029","article-title":"Continuous glucose monitoring for hypoglycaemia in children: Perspectives in 2020","volume":"21","author":"Worth","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2337\/DC19-0888","article-title":"Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/DC19-1610","article-title":"Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): A prospective observational real-world cohort study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/DS20-0069","article-title":"Use of flash continuous glucose monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy","volume":"34","author":"Wright","year":"2021","journal-title":"Diabetes Spectr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/DC19-1358","article-title":"Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: A multicenter analysis of 3,553 subjects from the DPV registry","volume":"43","author":"Tauschmann","year":"2020","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/DC17-1821","article-title":"Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: The DIAMOND randomized trial","volume":"41","author":"Wan","year":"2018","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/DC19-2213","article-title":"Long-term cost-effectiveness of dexcom G6 real-time continuous glucose monitoring versus self-monitoring of blood glucose in patients with type 1 diabetes in the U.K","volume":"43","author":"Roze","year":"2020","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/1932296816628547","article-title":"The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes","volume":"10","author":"Fonda","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.051979","article-title":"The continuous glucose monitoring sensor in neonatal intensive care","volume":"90","author":"Beardsall","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-301661","article-title":"Validation of the continuous glucose monitoring sensor in preterm infants","volume":"98","author":"Beardsall","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgab601","article-title":"Continuous glucose monitoring in the management of neonates with persistent hypoglycaemia and congenital hyperinsulinism","volume":"107","author":"Win","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2021-0414","article-title":"The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia","volume":"34","author":"Vijayanand","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s13633-018-0057-2","article-title":"Continuous flash glucose monitoring in children with congenital hyperinsulinism; first report on accuracy and patient experience","volume":"2018","author":"Alsaffar","year":"2018","journal-title":"Int J Pediatr Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000506230","article-title":"Continuous glucose monitoring systems: Are they useful for evaluating glycemic control in children with hyperinsulinism","volume":"92","author":"Rayannavar","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1016072","article-title":"The hypoglycaemia error grid: a UK-wide consensus on CGM accuracy assessment in hyperinsulinism","author":"Worth","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2013.186","article-title":"Continuous glucose monitoring in children with glycogen storage disease type i","volume":"68","author":"Kasapkara","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0200-5","article-title":"Role of continuous glucose monitoring in the management of glycogen storage disorders","volume":"41","author":"Herbert","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac411","article-title":"A prospective study on continuous glucose monitoring in glycogen storage disease type ia: Toward glycemic targets","volume":"107","author":"Rossi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/15513815.2019.1692111","article-title":"Monitoring the frequency and duration of hypoglycemia in preterm infants and identifying associated factors","volume":"40","author":"Fern\u00e1ndez Mart\u00ednez M del","year":"2021","journal-title":"Fetal Pediatr Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30367-9","article-title":"Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial","volume":"5","author":"Beardsall","year":"2021","journal-title":"Lancet Child Adolesc Heal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"0","DOI":"10.4274\/jcrpe.galenos.2021.2021.0121","article-title":"Maltodextrin may be a promising treatment modality after near-total pancreatectomy in infants younger than six months with persistent hyperinsulinism: A case report","author":"Denkboy Ongen","year":"2012","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jpem-2022-0224","article-title":"Continuous glucose monitoring in an infant with panhypopituitarism having hypoglycemia on growth hormone therapy","volume":"2975","author":"Kiuchi","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B35","article-title":"The behaviour change behind a successful pilot of hypoglycaemia reduction with HYPO-CHEAT","author":"Worth","year":"2022","journal-title":"Under Rev Digit Heal"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9335-3","article-title":"The use of continuous glucose monitoring in the practical management of glycogen storage disorders","volume":"34","author":"White","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112140-20210321-00235","article-title":"[The application of continuous glucose monitoring in the management of hepatic glycogen storage disease]","volume":"59","author":"Du","year":"2021","journal-title":"Chin J Pediatr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.02.008","article-title":"Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry","volume":"126","author":"Kaiser","year":"2019","journal-title":"Mol Genet Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.1423","article-title":"Continuous glucose monitoring in the management of hypoglycemia in TANGO2","volume":"5","author":"Esper","year":"2021","journal-title":"J Endocr Soc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/archdischild-2022-323872","article-title":"Case for funding of continuous glucose monitoring systems for patients with recurrent hypoglycaemia","author":"Ng","year":"2022","journal-title":"Arch Dis Child"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12178","article-title":"Research priorities for liver glycogen storage disease : An international priority setting partnership with the","volume":"43","author":"Peeks","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12383","article-title":"A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management","volume":"44","author":"Peeks","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.894559","article-title":"Families\u2019 experiences of continuous glucose monitoring in the management of congenital hyperinsulinism: A thematic analysis","author":"Auckburally","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","unstructured":"Continuous glucose monitoring for hypoglycaemia: the unheard patient voice IN 60th annual meeting of the European society for paediatric endocrinology (ESPE)\n            AhmadS\n            WorthC\n            AuckburallyS\n            Salomon-EstebanezM\n            O\u2019SheaE\n            WorthingtonS\n          2022"},{"key":"B45","article-title":"The sustainable development goals report 2022","volume":"64","year":"2022","journal-title":"United Nations Publ issued by Dep Econ Soc Aff"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/bios8020043","article-title":"Continuous glucose monitoring in resource-constrained settings for hypoglycaemia detection: Looking at the problem from the other side of the coin","volume":"8","author":"Bila","year":"2018","journal-title":"Biosensors"},{"key":"B47","unstructured":"Mart\u00ednezC\n            RomeroC\n            VillalobosNS\n          What are pharma companies doing to expand access to insulin \u2013 and how can efforts be scaled up?2022"},{"key":"B48","unstructured":"Newborn mortalityWorld heal organ2022"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/39.5.273","article-title":"Hypoglycaemia: A common problem among uncomplicated newborn infants in Nepal","volume":"39","author":"Anderson","year":"1993","journal-title":"J Trop Pediatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1179\/2046905515Y.0000000034","article-title":"New technologies for essential newborn care in under-resourced areas: What is needed and how to deliver it","volume":"35","author":"Maynard","year":"2015","journal-title":"Paediatr Int Child Health"},{"key":"B51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia","volume":"122","author":"Burns","year":"2008","journal-title":"Pediatrics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(21)00090-0","article-title":"Epilepsy stigma in children in low-income and middle-income countries","volume":"5","author":"Kariuki","year":"2021","journal-title":"Lancet Child Adolesc Heal"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00595.x","article-title":"Epilepsy care in the world: Results of an ILAE\/IBE\/WHO global campaign against epilepsy survey","volume":"47","author":"Dua","year":"2006","journal-title":"Epilepsia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13388","article-title":"Systematic review of interventions for reducing stigma experienced by children with disabilities and their families in low- and middle-income countries: state of the evidence","volume":"25","author":"Smythe","year":"2020","journal-title":"Trop Med Int Heal"},{"key":"B55","volume-title":"Diabeter value-based healthcare delivery in diabetes diabeter: Value-based health care delivery in diabetes 1","author":"Deerberg-Wittram","year":"2016"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12555","article-title":"Towards values-based healthcare for inherited metabolic disorders: An overview of current practices for persons with liver glycogen storage disease and fatty acid oxidation disorders","volume":"45","author":"Venema","year":"2022","journal-title":"J Inherit Metab Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.36479\/jhe.v2i1.17","article-title":"Ruggedising biomedical devices for field-testing in resource-constrained environments: Context, issues and solutions","volume":"2","author":"Schopman","year":"2013","journal-title":"J Humanit Eng"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61127-1","article-title":"Technologies for global health","volume":"380","author":"Howitt","year":"2012","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijgo.2004.01.009","article-title":"Achieving appropriate design and widespread use of health care technologies in the developing world. overcoming obstacles that impede the adaptation and diffusion of priority technologies for primary health care","volume":"85","author":"Free","year":"2004","journal-title":"Int J Gynecol Obstet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjinnov-2020-000598","article-title":"Newborn care technology investments for LMIC settings: a CPAP approach","volume":"7","author":"Kasali","year":"2021","journal-title":"BMJ Innov"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1039\/d1sd00030f","article-title":"Recent advances in optical sensors for continuous glucose monitoring","author":"Ahmed","year":"2022","journal-title":"Sensors Diagnostics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s22020638","article-title":"Comprehensive review on wearable sweat-glucose sensors for continuous glucose monitoring","volume":"22","author":"Zafar","year":"2022","journal-title":"Sensors"},{"key":"B63","doi-asserted-by":"publisher","first-page":"031601","DOI":"10.1149\/2754-2726\/ac7abb","article-title":"Review\u2013electrochemistry and other emerging technologies for continuous glucose monitoring devices","volume":"1","author":"Kumar Das","year":"2022","journal-title":"ECS Sensors Plus"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/cnm.2833","article-title":"A review of personalized blood glucose prediction strategies for T1DM patients","volume":"33","author":"Oviedo","year":"2017","journal-title":"Int J numer method BioMed Eng"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: A randomized controlled trial","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Crit Care"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-316871","article-title":"Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants","volume":"105","author":"Beardsall","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/S20061705","article-title":"Prediction of nocturnal hypoglycemia in adults with type 1 diabetes under multiple daily injections using continuous glucose monitoring and physical activity monitor","volume":"20","author":"Bertachi","year":"2020","journal-title":"Sensors 2020 Vol 20 Page 1705"},{"key":"B68","unstructured":"Clinically accurate prediction of glucose levels in patients with type 1 diabetes\n            AmarY\n            ShiloS\n            OronT\n            AmarE\n            PhillipM\n            SegalE\n          2020"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/J.DIABRES.2020.108388","article-title":"Artificial intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during ramadan (The PROFAST \u2013 IT Ramadan study)","volume":"169","author":"Elhadd","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820922622","article-title":"Feature-based machine learning model for real-time hypoglycemia prediction","volume":"15","author":"Dave","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s21020546","article-title":"Machine learning techniques for hypoglycemia prediction: Trends and challenges","volume":"21","author":"Mujahid","year":"2021","journal-title":"Sensors (Switzerland)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2196\/22458","article-title":"Ability of current machine learning algorithms to predict and detect hypoglycemia in patients with diabetes mellitus: meta-analysis","volume":"6","author":"Kodama","year":"2021","journal-title":"JMIR Diabetes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0212-y","article-title":"An artificial intelligence decision support system for the management of type 1 diabetes","volume":"2","author":"Tyler","year":"2020","journal-title":"Nat Metab"},{"key":"B74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1932296819851135","article-title":"A modular safety system for an insulin dose recommender: A feasibility study","volume":"14","author":"Liu","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s20113214","article-title":"Artificial intelligence in decision support systems for type 1 diabetes","volume":"20","author":"Tyler","year":"2020","journal-title":"Sensors (Switzerland)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14286","article-title":"A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach","volume":"37","author":"Nano","year":"2020","journal-title":"Diabetes Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1624","article-title":"Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: A consensus report of the American association of clinical endocrinologists, the American association of diabetes educators, the American diabetes association, the endo","volume":"40","author":"Agiostratidou","year":"2017","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3223","article-title":"The digital phenotype","volume":"33","author":"Jain","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2217\/pme.13.57","article-title":"P4 medicine: How systems medicine will transform the healthcare sector and society","volume":"10","author":"Flores","year":"2013","journal-title":"Per Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/26957","article-title":"Indraneel Banerjee,MBBS m. clustering of hypoglycemia events in patients with hyperinsulinism: Extension of the digital phenotype through retrospective data analysis","volume":"23","author":"Worth","year":"2021","journal-title":"J Med Internet Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20552076221129712","article-title":"HYPO-CHEAT\u2019s aggregated weekly visualisations of risk reduce real world hypoglycaemia","volume":"8","author":"Worth","year":"2022","journal-title":"Digit Heal"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/BMJDRC-2022-002849","article-title":"Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset","volume":"10","author":"Worth","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B83","unstructured":"Glucose regulation in children with primary adrenal insufficiency: preliminary data\n            ParkJ\n            HawcuttD\n            ShantsilaH\n            LipG\n            BlairJ\n          2021"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2019.07.007","article-title":"Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes","volume":"98","author":"Woldaregay","year":"2019","journal-title":"Artif Intell Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818790994","article-title":"Behavior modification in prediabetes and diabetes: Potential use of real-time continuous glucose monitoring","volume":"13","author":"Ehrhardt","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2337\/cd19-0037","article-title":"Continuous glucose monitoring as a behavior modification tool","volume":"38","author":"Ehrhardt","year":"2020","journal-title":"Clin Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/978-3-030-53370-0_43","article-title":"Continuous glucose monitors as wearable lifestyle behavior change tools in obesity and diabetes","author":"Schembre","year":"2020","journal-title":"Obes Diabetes"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16183323","article-title":"Effect of diabetes education through pattern management on self-care and self-efficacy in patients with type 2 diabetes","volume":"16","author":"Lee","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: A multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvac060","article-title":"Continuous glucose monitoring profiles in healthy, nondiabetic young children","volume":"6","author":"Dubose","year":"2022","journal-title":"J Endocr Soc"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.858832","article-title":"Dynamic methods for childhood hypoglycemia phenotyping: A narrative review","volume":"13","author":"Rossi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/ACN3.51462","article-title":"Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome","volume":"8","author":"Logel","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-022-03556-z","article-title":"Impact of tight glycemic control and hypoglycemia after pediatric cardiac surgery on neurodevelopmental outcomes at three years of age: Findings from a randomized clinical trial","volume":"22","author":"Sadhwani","year":"2022","journal-title":"BMC Pediatr"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1159\/000525606","article-title":"Dasiglucagon treatment over 21 days in infants with congenital hyperinsulinism results in glycaemic stability and reduces requirement for intravenous glucose IN 60th annual meeting of the European society for paediatric endocrinology (ESPE)","volume":"95","author":"Banerjee","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1159\/000525606","article-title":"Results from a global, multi-center, phase 2b study (RIZE) in congenital hyperinsulinism: Characterization of a high unmet treatment need and glycemic response to RZ358 IN 60th annual meeting of the European society for paediatric endocrinology (ESPE)","volume":"95","author":"Demirbilek","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"B96","unstructured":"ClinicalTrials: A study of adeno-associated virus serotype 8-mediated gene transfer of glucose-6-Phosphatase in patients with glycogen storage disease type ia (GSDIa)2021"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1116864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T06:34:02Z","timestamp":1674455642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1116864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":96,"alternative-id":["10.3389\/fendo.2023.1116864"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1116864","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"article-number":"1116864"}}